Xiaowen Sun
机构：The University of Texas MD Anderson Cancer Center, Beijing Tsinghua Chang Gung Hospital · ORCID：0009-0002-2207-6789
发表论文 45 篇 · 总被引 379 次 · h-index 11
代表论文
- Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas (2024 · Clinical Cancer Research · 被引 8)
- Details Make a Difference: Object State-Sensitive Neurorobotic Task Planning (2024 · Lecture notes in computer science · 被引 2)
- Real world experience of anakinra for the treatment of immune effector cell-associated neurotoxicity syndrome in large B-cell lymphoma (2025 · Blood · 被引 1)
- Safety and efficacy of implanted port use for CAR T-cells infusion in large B-cell lymphoma (2025 · Blood)
- Impact of TP53 mutation status on cancer-specific survival after first-line treatment in lymphoplasmacytic lymphoma. (2025 · Journal of Clinical Oncology)
- The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer (2025 · BMC Cancer)